PRVA241115C32500
- 0.00
- 0.000.00%
Privia Health Newsroom
Investors Holding Back On Privia Health Group, Inc. (NASDAQ:PRVA)
Earnings Preview: PRVA to Report Financial Results Pre-market on November 07
Barclays Maintains Privia Health(PRVA.US) With Hold Rating, Maintains Target Price $19
Privia Health Group Reports FY Results
Privia Health Group Shares Are Trading Higher After the Company Announced Its Accountable Care Organizations Achieved Savings of $176.6 Million Through the Medicare Shared Savings Program for the 2023 Performance Year.
Evercore Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $22
Express News | Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program
Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down
KeyBanc Sees Hospitals Beating/raising With Q3 Earnings
What's Next for Health Insurers as Medicare Finalizes 2025 Star Ratings?
Privia Health Price Target Announced at $23.00/Share by Keybanc
Privia Health Initiated With an Overweight at KeyBanc
Privia Health Group Inc (PRVA) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...
Privia Health to Report Third Quarter 2024 Results on Thursday, November 7
Privia Health Group Insiders Placed Bullish Bets Worth US$9.31m
Morgan Stanley Identifies 39 Stocks Likely to Face Tax Loss Selling Pressure
William Blair Initiates Privia Health(PRVA.US) With Buy Rating
Privia Health Group Insider Sold Shares Worth $2,500,127, According to a Recent SEC Filing
The Returns On Capital At Privia Health Group (NASDAQ:PRVA) Don't Inspire Confidence
Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating